Literature DB >> 17934868

The molecular genetics of adrenocortical carcinoma.

Ferdous M Barlaskar1, Gary D Hammer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17934868     DOI： 10.1007/s11154-007-9057-x

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  56 in total

Review 1.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

Review 2.  The p53 mutation "gradient effect" and its clinical implications.

Authors:  Gerard P Zambetti
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

Review 3.  Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors.

Authors:  Michael D Gordon; Roel Nusse
Journal:  J Biol Chem       Date:  2006-06-22       Impact factor: 5.157

4.  Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy.

Authors:  Florence de Fraipont; Michelle El Atifi; Nadia Cherradi; Gwennaelle Le Moigne; Geneviève Defaye; Rémi Houlgatte; Jérôme Bertherat; Xavier Bertagna; Pierre-François Plouin; Eric Baudin; François Berger; Christine Gicquel; Olivier Chabre; Jean-Jacques Feige
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

5.  Restoration of p53 function leads to tumour regression in vivo.

Authors:  Andrea Ventura; David G Kirsch; Margaret E McLaughlin; David A Tuveson; Jan Grimm; Laura Lintault; Jamie Newman; Elizabeth E Reczek; Ralph Weissleder; Tyler Jacks
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

Review 6.  The role of p53 in human cancer.

Authors:  D Malkin
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

7.  Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.

Authors:  Frédérique Tissier; Catherine Cavard; Lionel Groussin; Karine Perlemoine; Gwladys Fumey; Anne-Marie Hagneré; Fernande René-Corail; Eric Jullian; Christine Gicquel; Xavier Bertagna; Marie-Cécile Vacher-Lavenu; Christine Perret; Jérôme Bertherat
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

Review 8.  Adrenocortical cells with stem/progenitor cell properties: recent advances.

Authors:  Alex C Kim; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2007-01-19       Impact factor: 4.102

Review 9.  Management of patients with adrenal cancer: recommendations of an international consensus conference.

Authors:  D E Schteingart; G M Doherty; P G Gauger; T J Giordano; G D Hammer; M Korobkin; F P Worden
Journal:  Endocr Relat Cancer       Date:  2005-09       Impact factor: 5.678

Review 10.  Adrenocortical cancer: pathophysiology and clinical management.

Authors:  Rossella Libè; Amato Fratticci; Jérôme Bertherat
Journal:  Endocr Relat Cancer       Date:  2007-03       Impact factor: 5.678
View more
  16 in total

Review 1.  Review paper: origin and molecular pathology of adrenocortical neoplasms.

Authors:  M Bielinska; H Parviainen; S Kiiveri; M Heikinheimo; D B Wilson
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

2.  Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).

Authors:  A Stigliano; I Chiodini; R Giordano; A Faggiano; L Canu; S Della Casa; P Loli; M Luconi; F Mantero; M Terzolo
Journal:  J Endocrinol Invest       Date:  2015-07-14       Impact factor: 4.256

3.  Pediatric adrenocortical neoplasms: immunohistochemical expression of p57 identifies loss of heterozygosity and abnormal imprinting of the 11p15.5.

Authors:  Isabella Giovannoni; Renata Boldrini; Maria Chiara Benedetti; Alessandro Inserra; Maria Debora De Pasquale; Paola Francalanci
Journal:  Pediatr Res       Date:  2016-11-14       Impact factor: 3.756

4.  Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up.

Authors:  F Ceccato; G Occhi; N M Albiger; S Rizzati; S Ferasin; G Trivellin; F Mantero; C Scaroni
Journal:  J Endocrinol Invest       Date:  2010-07-01       Impact factor: 4.256

Review 5.  Molecular markers of adrenocortical tumors.

Authors:  Meenu Jain; Nesrin Rechache; Electron Kebebew
Journal:  J Surg Oncol       Date:  2012-04-13       Impact factor: 3.454

6.  GATA4 is a critical regulator of gonadectomy-induced adrenocortical tumorigenesis in mice.

Authors:  Justyna Krachulec; Melanie Vetter; Anja Schrade; Ann-Kathrin Löbs; Malgorzata Bielinska; Rebecca Cochran; Antti Kyrönlahti; Marjut Pihlajoki; Helka Parviainen; Patrick Y Jay; Markku Heikinheimo; David B Wilson
Journal:  Endocrinology       Date:  2012-03-28       Impact factor: 4.736

Review 7.  Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician.

Authors:  Alexis Teplick; Megan Kowalski; Jaclyn A Biegel; Kim E Nichols
Journal:  Eur J Pediatr       Date:  2011-01-06       Impact factor: 3.183

8.  E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis.

Authors:  Anna Ehrlund; Elin Holter Anthonisen; Nina Gustafsson; Nicolas Venteclef; Kirsten Robertson Remen; Anastasios E Damdimopoulos; Anastasia Galeeva; Markku Pelto-Huikko; Enzo Lalli; Knut R Steffensen; Jan-Ake Gustafsson; Eckardt Treuter
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

Review 9.  New methods for investigating experimental human adrenal tumorigenesis.

Authors:  Cibele C Cardoso; Stefan R Bornstein; Peter J Hornsby
Journal:  Mol Cell Endocrinol       Date:  2008-11-13       Impact factor: 4.102

Review 10.  In search of adrenocortical stem and progenitor cells.

Authors:  Alex C Kim; Ferdous M Barlaskar; Joanne H Heaton; Tobias Else; Victoria R Kelly; Kenneth T Krill; Joshua O Scheys; Derek P Simon; Alessia Trovato; Wei-Hsiung Yang; Gary D Hammer
Journal:  Endocr Rev       Date:  2009-04-29       Impact factor: 19.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.